The purpose of this narrative review is to bring together the most recent epidemiologic,
preclinical, and clinical findings to offer our perspective on best practices for managing …

Background Acinetobacter baumannii is a nosocomial pathogen that has emerged as a
major threat in the health-care settings, particularly intensive care units (ICUs). The aim of …

Multidrug resistance of bacteria has prompted intensive development work on new
medicines, but also the search for effective options among the oldest antibiotics. Although …

Spiders produce webs, which are still a largely unexplored source of antibacterial
compounds, although the reports of its application in the medical field. Therefore, this study …

Multidrug-resistant microbial infections and the scarce availability of new antibiotics capable
of eradicating them are posing a serious problem to global health security. Among the …

Acinetobacter baumannii armed with multidrug resistance (MDR) and biofilm-forming ability
is increasingly recognized as an alarming pathogen. A deeper comprehension of the …

Background The upgrowth and rapid prevalence of pandrug-resistant Acinetobacter
baumannii strains that have a pathogenic activity to cause several infections are of …

Acinetobacter baumannii is a Gram-negative priority pathogen that can readily overcome
antibiotic treatment through a range of intrinsic and acquired resistance mechanisms …

Acinetobacter baumannii is an important Gram-negative opportunistic pathogen that is
responsible for many nosocomial infections. This etiologic agent has acquired, over the …

Background The emergence and spread of extended-spectrum β-lactamases (ESβLs) and
carbapenemase (CP) producing gram negative non-fermenters are becoming a serious …